Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Change in Accured Expenses (2020 - 2026)

Climb Bio filings provide 7 years of Change in Accured Expenses readings, the most recent being -$1.5 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 175.28% to -$1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.6 million through Mar 2026, down 184.43% year-over-year, with the annual reading at $1.4 million for FY2024, N/A changed from the prior year.
  • Change in Accured Expenses hit -$1.5 million in Q1 2026 for Climb Bio, down from -$152000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.8 million in Q3 2023 and bottomed at -$1.7 million in Q3 2022.
  • Average Change in Accured Expenses over 5 years is $21125.0, with a median of -$28500.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 373.15% in 2025, while the deepest fall reached 933.68% in 2025.
  • Climb Bio's Change in Accured Expenses stood at $613000.0 in 2022, then soared by 355.46% to $2.8 million in 2023, then plummeted by 63.32% to $1.0 million in 2024, then tumbled by 114.84% to -$152000.0 in 2025, then plummeted by 907.89% to -$1.5 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Change in Accured Expenses are -$1.5 million (Q1 2026), -$152000.0 (Q4 2025), and -$792000.0 (Q3 2025).